Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Stabilized BCL9 peptides for treatment of aberrant WNT signaling

Stabilized BCL9 peptides for treatment of aberrant WNT signaling

US Patent 11498947 · Granted Nov 15, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stabilized BCL9 peptides for treatment of aberrant Wnt signaling2025
BCL9 peptides and variants thereof2023
Stabilized BCL9 peptides for treatment of aberrant WNT signaling2021
Visual neuromodulation system and methods for treatments of visually triggered m2020
Apparatus and method for detecting and classifying atherosclerotic plaque hemorr2010